Compare XBIT & WYY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XBIT | WYY |
|---|---|---|
| Founded | 2005 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.6M | 62.9M |
| IPO Year | 2015 | 2005 |
| Metric | XBIT | WYY |
|---|---|---|
| Price | $1.95 | $5.91 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 82.6K | ★ 122.0K |
| Earning Date | 11-12-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $150,545,364.00 |
| Revenue This Year | N/A | $12.26 |
| Revenue Next Year | $30.47 | $25.66 |
| P/E Ratio | ★ N/A | $617.00 |
| Revenue Growth | N/A | ★ 5.59 |
| 52 Week Low | $1.80 | $3.96 |
| 52 Week High | $2.73 | $24.30 |
| Indicator | XBIT | WYY |
|---|---|---|
| Relative Strength Index (RSI) | 45.36 | 34.96 |
| Support Level | $1.83 | $5.60 |
| Resistance Level | $2.42 | $7.74 |
| Average True Range (ATR) | 0.11 | 0.42 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 45.45 | 8.33 |
XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.
WidePoint Corp is a provider of Technology Management as a Service (TMaaS) that consists of federally certified communications management, identity management, interactive bill presentment and analytics, and an Information Technology as a Service solution. Its solutions include Telecom Lifecycle Management, Digital billing communications solutions, and Mobile and Identity management. Geographically, the company generates a majority of its revenue from the United States and the rest from Europe.